Optimer Pharmaceuticals, Inc.
Records under this name other than patents Optimer Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Optimer Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,906,489 | 18-Membered Macrocycles and Analogs Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 8,518,899 | Macrocyclic Polymorphs, Compositions Comprising Such Polymorphs and Methods of Use and Manufacture Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 8,445,654 | Antibiotic Macrocycle Compounds and Methods of Manufacture and Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 8,916,527 | Antibiotic Macrocycle Compounds and Methods of Manufacture and Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 8,044,030 | Antibiotic Macrocycle Compounds and Methods of Mnaufacture and Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 8,883,986 | Macrolide Polymorphs, Compositions Comprising Such Polymorphs, and Methods of Use and Manufacture Thereof Formerly held Grace period ended · Low confidence | Grace period ended | Low confidence | |
| US 8,586,551 | 18-Membered Macrocycles and Analogs Thereof Formerly held Lapsed on the fee record Ended Nov 19, 2025 · High confidence | Lapsed on the fee record | Ended Nov 19, 2025 | High confidence |
| US 7,378,508 | Polymorphic Crystalline Forms of Tiacumicin B Formerly held Term ended Term ended Jan 31, 2025 · High confidence | Term ended | Term ended Jan 31, 2025 | High confidence |
| US 7,863,249 | Macrolide Polymorphs, Compositions Comprising Such Polymorphs, and Methods of Use and Manufacture Thereof Formerly held Term ended Term ended Jan 31, 2025 · High confidence | Term ended | Term ended Jan 31, 2025 | High confidence |
| US 8,859,510 | Macrocyclic Polymorphs, Compositions Comprising Such Polymorphs, and Methods of Use and Manufacture Thereof Formerly held Term ended Term ended Jan 31, 2025 · High confidence | Term ended | Term ended Jan 31, 2025 | High confidence |